title: Hepatorenal syndrome precipitated  by infective endocarditis.
authors: Leeds General Infirmary, Leeds, UK. peysh@doctors.org.uk
authors: Peysh A
authors: PA
authors: Patel
authors: Emma
authors: E
authors: Lowe
authors: Wazir
authors: W
authors: Baig
authors: Jonathan
authors: J
authors: Sandoe
mesh_terms: D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects; D000075202:Contraindications; D017576:Daptomycin / Q000008:administration & dosage / Q000009:adverse effects; D018450:Disease Progression; D057915:Drug Substitution; D017548:Echocardiography, Transesophageal; D004696:Endocarditis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology; D017809:Fatal Outcome; D005440:Fluid Therapy; D006501:Hepatic Encephalopathy / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D006530:Hepatorenal Syndrome / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D007677:Kidney Function Tests; D016031:Liver Transplantation; D008297:Male; D008826:Microbial Sensitivity Tests; D012293:Rifampin / Q000008:administration & dosage / Q000009:adverse effects; D013203:Staphylococcal Infections / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D057787:Staphylococcus lugdunensis / Q000187:drug effects / Q000302:isolation & purification* / Q000472:pathogenicity; D014640:Vancomycin / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D000900:Anti-Bacterial Agents; D014640:Vancomycin; D017576:Daptomycin; D012293:Rifampin